Cargando…
Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
Tyrosinemia type I (HTI) is treated with nitisinone, a tyrosine (Tyr) and phenylalanine (Phe)-restricted diet, and supplemented with a Tyr/Phe-free protein substitute (PS). Casein glycomacropeptide (CGMP), a bioactive peptide, is an alternative protein source to traditional amino acids (L-AA). CGMP...
Autores principales: | Daly, Anne, Evans, Sharon, Pinto, Alex, Ashmore, Catherine, MacDonald, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467066/ https://www.ncbi.nlm.nih.gov/pubmed/34579102 http://dx.doi.org/10.3390/nu13093224 |
Ejemplares similares
-
The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020) -
Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
por: Delsoglio, Marta, et al.
Publicado: (2023) -
Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020) -
Glycomacropeptide in PKU—Does It Live Up to Its Potential?
por: Daly, Anne, et al.
Publicado: (2022) -
Growth and Body Composition in PKU Children—A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes
por: Daly, Anne, et al.
Publicado: (2021)